LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 68

Search options

  1. Article ; Online: Role of device therapy in left ventricular noncompaction cardiomyopathy: is it different from other causes of heart failure?

    Fung, Jeffrey W H

    Heart rhythm

    2010  Volume 7, Issue 11, Page(s) 1550–1551

    MeSH term(s) Cardiac Resynchronization Therapy ; Cardiomyopathies/therapy ; Humans ; Treatment Outcome
    Language English
    Publishing date 2010-11
    Publishing country United States
    Document type Comment ; Editorial
    ZDB-ID 2229357-7
    ISSN 1556-3871 ; 1547-5271
    ISSN (online) 1556-3871
    ISSN 1547-5271
    DOI 10.1016/j.hrthm.2010.07.024
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Recurrence patterns among patients with sinonasal mucosal melanoma: A multi-institutional study.

    Pandrangi, Vivek C / Mace, Jess C / Abiri, Arash / Adappa, Nithin D / Beswick, Daniel M / Chang, Eugene H / Eide, Jacob G / Fung, Nicholas / Hong, Michelle / Johnson, Brian J / Kohanski, Michael A / Kshirsagar, Rijul S / Kuan, Edward C / Le, Christopher H / Lee, Jivianne T / Nabavizadeh, Seyed A / Obermeyer, Isaac P / Palmer, James N / Pinheiro-Neto, Carlos D /
    Smith, Timothy L / Snyderman, Carl H / Suh, Jeffrey D / Wang, Eric W / Wang, Marilene B / Choby, Garret / Geltzeiler, Mathew

    International forum of allergy & rhinology

    2023  Volume 13, Issue 12, Page(s) 2156–2164

    Abstract: Objective: To evaluate recurrence patterns and survival after recurrence among patients with sinonasal mucosal melanoma (SNMM).: Methods: This was a multi-institutional retrospective review from seven U.S. institutions of patients with SNMM from 1991 ...

    Abstract Objective: To evaluate recurrence patterns and survival after recurrence among patients with sinonasal mucosal melanoma (SNMM).
    Methods: This was a multi-institutional retrospective review from seven U.S. institutions of patients with SNMM from 1991 to 2022. Recurrence was categorized as local, regional, distant, or multifocal. Kaplan-Meier tests were used to evaluate disease-free survival (DFS), overall survival (OS), and post-recurrence survival (PRS) reported with standard errors (SE) and log-rank testing used for comparison. Cox-regression was further used, with hazard ratios (HR) and 95% confidence intervals (CI) reported.
    Results: Among 196 patients with SNMM, there were 146 patients with recurrence (74.5%). Among all patients, 60-month DFS (SE) was 15.5% (2.9%), 60-month OS (SE) was 44.7% (3.7%), mean age ± standard deviation at diagnosis was 69.7 ± 12.5 years, and 54.6% were female. In 26 patients who underwent primary treatment of the neck, 60-month DFS did not differ from no treatment (p > 0.05). Isolated distant recurrence was most common (42.8%), followed by local (28.3%), multifocal (20.7%), and regional recurrence (8.3%). Among patients with regional recurrence in the neck, there was no 60-month PRS benefit for patients undergoing salvage neck dissection or radiation (p > 0.05). Among patients with distant recurrence, only immunotherapy was associated with improved 12-month PRS (HR = 0.32, 95% CI = 0.11-0.92, p = 0.034), and no treatment group was associated with improved 24- or 60-month PRS (p > 0.05).
    Conclusion: SNMM is associated with a high recurrence rate and poor survival. Primary treatment of the neck was not associated with reduced recurrence, and immunotherapy for treatment of distant recurrence was associated with increased 12-month PRS.
    MeSH term(s) Female ; Humans ; Male ; Disease-Free Survival ; Melanoma/therapy ; Nasal Mucosa ; Neoplasm Recurrence, Local/epidemiology ; Paranasal Sinus Neoplasms/surgery ; Retrospective Studies ; Survival Rate ; Middle Aged ; Aged ; Aged, 80 and over
    Language English
    Publishing date 2023-06-15
    Publishing country United States
    Document type Multicenter Study ; Journal Article
    ZDB-ID 2625826-2
    ISSN 2042-6984 ; 2042-6976
    ISSN (online) 2042-6984
    ISSN 2042-6976
    DOI 10.1002/alr.23204
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Regression of non-compaction in left ventricular non-compaction cardiomyopathy by cardiac contractility modulation.

    Wong, Philip H C / Fung, Jeffrey W H

    International journal of cardiology

    2012  Volume 154, Issue 3, Page(s) e50–1

    MeSH term(s) Cardiac Pacing, Artificial ; Heart Failure/etiology ; Heart Failure/therapy ; Humans ; Isolated Noncompaction of the Ventricular Myocardium/complications ; Male ; Middle Aged ; Pacemaker, Artificial
    Language English
    Publishing date 2012-02-09
    Publishing country Netherlands
    Document type Case Reports ; Letter
    ZDB-ID 779519-1
    ISSN 1874-1754 ; 0167-5273
    ISSN (online) 1874-1754
    ISSN 0167-5273
    DOI 10.1016/j.ijcard.2011.06.040
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Seizure clustering during presurgical electroencephalographic monitoring in children.

    Fung, France W / Libenson, Mark H / Bolton, Jeffrey / Pearl, Phillip L / Kapur, Kush / Marti, Candice / Paris, Ann / Bergin, Ann M / Harini, Chellamani

    Epilepsy & behavior : E&B

    2018  Volume 80, Page(s) 291–295

    Abstract: Background: Presurgical evaluation with antiseizure medication tapering in patients with refractory epilepsy places them at risk for seizure clustering or prolonged seizures. We looked at the occurrence of seizure clustering (3 or more seizures within ... ...

    Abstract Background: Presurgical evaluation with antiseizure medication tapering in patients with refractory epilepsy places them at risk for seizure clustering or prolonged seizures. We looked at the occurrence of seizure clustering (3 or more seizures within 24h) and prolonged seizures and the factors that influence seizure clustering and affect length of stay (LOS) in pediatric patients during presurgical monitoring.
    Methods: We retrospectively reviewed the medical records of all consecutive admissions to the epilepsy monitoring unit (EMU) and included patients undergoing noninvasive presurgical evaluation. Data were extracted regarding demographics, seizure history, details of the EMU admission including occurrence of seizure clusters, prolonged seizures, status epilepticus, treatment, and LOS.
    Results: Sixty-nine patients met our inclusion criteria. Seizure clustering during monitoring was observed in 33 patients (48%). Prolonged seizures lasting >5min was observed in 14 (20%) patients including 2 with status epilepticus (3%). Seizure clusters necessitated rescue treatment in around 30%. History of seizure clustering at home was the only factor associated with the occurrence of seizure clustering during the EMU stay (p<0.0001). The LOS did not differ significantly between patients who had seizure clustering during monitoring versus those who did not (p=0.369).
    Conclusions: Seizure clustering was common in children undergoing presurgical monitoring and seen especially in those with a history of seizure clustering at home. Occurrence of seizure clustering did not prolong the LOS but necessitated the use of rescue medications in about a third of the patients with seizure clusters due to multiple seizures.
    MeSH term(s) Adolescent ; Child ; Electroencephalography/methods ; Electroencephalography/statistics & numerical data ; Epilepsy/diagnosis ; Epilepsy/drug therapy ; Epilepsy/pathology ; Epilepsy/surgery ; Female ; Hospital Units ; Hospitalization ; Humans ; Length of Stay ; Male ; Monitoring, Ambulatory ; Monitoring, Physiologic/methods ; Monitoring, Physiologic/statistics & numerical data ; Preoperative Care/methods ; Preoperative Care/statistics & numerical data ; Preoperative Period ; Retrospective Studies ; Seizures/diagnosis ; Seizures/epidemiology ; Seizures/surgery ; Status Epilepticus
    Language English
    Publishing date 2018-02-03
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2010587-3
    ISSN 1525-5069 ; 1525-5050
    ISSN (online) 1525-5069
    ISSN 1525-5050
    DOI 10.1016/j.yebeh.2018.01.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Should we switch to RVOT pacing for all now? Not yet.

    Fung, Jeffrey W H / Yu, Cheuk-Man

    Journal of cardiovascular electrophysiology

    2010  Volume 21, Issue 10, Page(s) 1127–1129

    MeSH term(s) Aged ; Cardiac Pacing, Artificial/adverse effects ; Female ; Heart Conduction System/physiopathology ; Heart Ventricles/physiopathology ; Humans ; Male ; Ventricular Dysfunction, Left/diagnosis ; Ventricular Dysfunction, Left/etiology ; Ventricular Dysfunction, Left/physiopathology
    Language English
    Publishing date 2010-10
    Publishing country United States
    Document type Comment ; Editorial
    ZDB-ID 1025989-2
    ISSN 1540-8167 ; 1045-3873
    ISSN (online) 1540-8167
    ISSN 1045-3873
    DOI 10.1111/j.1540-8167.2010.01821.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The 2010 update of the ESC guidelines for the management of atrial fibrillation. Beyond the rate or rhythm strategy debate.

    Fung, Jeffrey W H / Yu, Cheuk-Man

    Circulation journal : official journal of the Japanese Circulation Society

    2010  Volume 74, Issue 12, Page(s) 2538–2541

    MeSH term(s) Atrial Fibrillation/epidemiology ; Atrial Fibrillation/physiopathology ; Atrial Fibrillation/therapy ; Humans ; Practice Guidelines as Topic
    Language English
    Publishing date 2010-11-02
    Publishing country Japan
    Document type Journal Article ; Review
    ZDB-ID 2068090-9
    ISSN 1347-4820 ; 1346-9843
    ISSN (online) 1347-4820
    ISSN 1346-9843
    DOI 10.1253/circj.cj-10-1042
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Assessment of pharyngeal motor function using a novel velopharyngeal squeeze maneuver and a novel endoscopic pharyngeal contraction grade scale in patients with dysphagia after radiotherapy for nasopharyngeal carcinoma.

    Ku, Peter K M / Vlantis, Alexander C / Hui, Thomas S C / Yeung, David C M / Lee, Alex K F / Law, Thomas / Chan, Simon Y P / Poon, Esther S M / Lee, Sophie Y Y / Chan, Becky Y T / Cheung, Twinky Y L / Lok, Laurie Y W / Cheng, Dennis T H / Li, Jade W S / Yam, Ken C W / Ho, Christina S M / Fung, Kristy P T / Chan, Coco S Y / Wang, William H S /
    Wong, Jeffrey K T / Abdullah, Victor / van Hasselt, Andrew / Tong, Michael C F

    Head & neck

    2021  Volume 43, Issue 11, Page(s) 3586–3597

    Abstract: Background: To investigate a novel velopharyngeal squeeze maneuver (VPSM) and novel endoscopic pharyngeal contraction grade (EPCG) scale for the evaluation of pharyngeal motor function.: Methods: During endoscopic examination of 77 post-irradiated ... ...

    Abstract Background: To investigate a novel velopharyngeal squeeze maneuver (VPSM) and novel endoscopic pharyngeal contraction grade (EPCG) scale for the evaluation of pharyngeal motor function.
    Methods: During endoscopic examination of 77 post-irradiated nasopharyngeal carcinoma patients and control subjects, VPSM was rated and lateral pharyngeal wall movement graded with EPCG scale during swallowing. Pharyngeal constriction ratio (PCR) measured by videofluoroscopy was used for correlation.
    Results: VPSM and EPCG scale showed almost perfect intra-rater and inter-rater reliability (Kappa: >0.90). VPSM was present in 61% of patients suggesting good pharyngeal motor function. VPSM was predictive of EPCG scale (Wald statistic = 29.99, p < 0.001). EPCG scale also correlated strongly with PCR (r: 0.812) and was predictive for aspiration (odds ratio: 22.14 [95% CI 5.01-97.89, p < 0.001]).
    Conclusions: VPSM and EPCG scale are two novel tools to assess pharyngeal motor function, and both correlate well with pharyngeal contractility and aspiration.
    MeSH term(s) Deglutition ; Deglutition Disorders/diagnosis ; Deglutition Disorders/etiology ; Humans ; Nasopharyngeal Carcinoma/radiotherapy ; Nasopharyngeal Neoplasms/radiotherapy ; Pharynx/diagnostic imaging ; Reproducibility of Results
    Language English
    Publishing date 2021-09-15
    Publishing country United States
    Document type Journal Article
    ZDB-ID 645165-2
    ISSN 1097-0347 ; 0148-6403 ; 1043-3074
    ISSN (online) 1097-0347
    ISSN 0148-6403 ; 1043-3074
    DOI 10.1002/hed.26871
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Screening for Fabry Disease in patients with unexplained left ventricular hypertrophy.

    Sadasivan, Chandu / Chow, Josie T Y / Sheng, Bun / Chan, David K H / Fan, Yiting / Choi, Paul C L / Wong, Jeffrey K T / Tong, Mabel M B / Chan, Tsz-Ngai / Fung, Erik / Kam, Kevin K H / Chan, Joseph Y S / Chi, Wai-Kin / Paterson, D Ian / Senaratne, Manohara / Brass, Neil / Oudit, Gavin Y / Lee, Alex P W

    PloS one

    2020  Volume 15, Issue 9, Page(s) e0239675

    Abstract: Fabry Disease (FD) is a systemic disorder that can result in cardiovascular, renal, and neurovascular disease leading to reduced life expectancy. FD should be considered in the differential of all patients with unexplained left ventricular hypertrophy ( ... ...

    Abstract Fabry Disease (FD) is a systemic disorder that can result in cardiovascular, renal, and neurovascular disease leading to reduced life expectancy. FD should be considered in the differential of all patients with unexplained left ventricular hypertrophy (LVH). We therefore performed a prospective screening study in Edmonton and Hong Kong using Dried Blood Spot (DBS) testing on patients with undiagnosed LVH. Participants found to have unexplained LVH on echocardiography were invited to participate and subsequently subjected to DBS testing. DBS testing was used to measure α-galactosidase (α-GAL) enzyme activity and for mutation analysis of the α-galactosidase (GLA) gene, both of which are required to make a diagnosis of FD. DBS testing was performed as a screening tool on patients (n = 266) in Edmonton and Hong Kong, allowing for detection of five patients with FD (2% prevalence of FD) and one patient with hydroxychloroquine-induced phenocopy. Left ventricular mass index (LVMI) by GLA genotype showed a higher LVMI in patients with IVS4 + 919G > A mutations compared to those without the mutation. Two patients were initiated on ERT and hydroxychloroquine was discontinued in the patient with a phenocopy of FD. Overall, we detected FD in 2% of our screening cohort using DBS testing as an effective and easy to administer screening tool in patients with unexplained LVH. Utilizing DBS testing to screen for FD in patients with otherwise undiagnosed LVH is clinically important due to the availability of effective therapies and the value of cascade screening in extended families.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; DNA Mutational Analysis ; Diagnosis, Differential ; Dried Blood Spot Testing ; Echocardiography ; Fabry Disease/diagnosis ; Fabry Disease/enzymology ; Fabry Disease/epidemiology ; Female ; Genotype ; Hong Kong/epidemiology ; Humans ; Hypertrophy, Left Ventricular/diagnosis ; Hypertrophy, Left Ventricular/enzymology ; Hypertrophy, Left Ventricular/epidemiology ; Male ; Mass Screening/methods ; Middle Aged ; Mutation ; Phenotype ; Prospective Studies ; alpha-Galactosidase/genetics
    Chemical Substances GLA protein, human (EC 3.2.1.22) ; alpha-Galactosidase (EC 3.2.1.22)
    Keywords covid19
    Language English
    Publishing date 2020-09-28
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0239675
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Real-World Assessment of Acute Left Ventricular Lead Implant Success and Complication Rates: Results from the Attain Success Clinical Trial.

    Hummel, John D / Coppess, Mark A / Osborn, Jeffrey S / Yee, Raymond / Fung, Jeffrey W H / Augostini, Ralph / Li, Shelby / Hine, Douglas / Singh, Jagmeet P

    Pacing and clinical electrophysiology : PACE

    2016  Volume 39, Issue 11, Page(s) 1246–1253

    Abstract: Background: Left ventricular lead (LVL) implant success rates have historically ranged between 70.5% and 95.5%. To date, there are few large studies that evaluate LVL implant success utilizing a single family of delivery catheters and leads. The Attain ... ...

    Abstract Background: Left ventricular lead (LVL) implant success rates have historically ranged between 70.5% and 95.5%. To date, there are few large studies that evaluate LVL implant success utilizing a single family of delivery catheters and leads. The Attain Success study was a prospective nonrandomized multicenter global study with the main objectives of assessing single-system LVL implant success and complication rates.
    Methods: Patients undergoing cardiac resynchronization therapy implantation were eligible for enrollment. There was no prespecified level of experience for investigator participation. LVL implant success and complication rates were assessed though 3 months of follow-up.
    Results: A total of 2,014 patients (69.1 ± 12.0 years, 71% male and 38% atrial fibrillation) were enrolled from 114 centers with a follow-up of 3.5 ± 2.1 months. Coronary sinus cannulation success rate was 96.4% with Attain Family delivery catheters. Implant success rate for Attain Family leads using Attain Family catheters was 94.0%; overall LVL implant success rate was 97.1%. Median procedure time was 4 minutes for cannulation and 9 minutes for LVL placement. Median fluoroscopy time was 17 minutes and median contrast used was 25 cc. There were 55 catheter or LVL-related complications in 53 subjects; the majority were LVL dislodgements (34, 1.7%) and extracardiac stimulation (11, 0.5%). The Kaplan-Meier estimate of the 3-month complication probability was 2.6%.
    Conclusion: This study represents the largest prospective evaluation of LVL implantation to date, revealing a high LVL implant success rate and low complication rate using a single family of leads and delivery catheters.
    MeSH term(s) Aged ; Cardiac Resynchronization Therapy ; Female ; Follow-Up Studies ; Heart Ventricles ; Humans ; Male ; Postoperative Complications ; Prospective Studies ; Prostheses and Implants ; Treatment Outcome
    Language English
    Publishing date 2016-11
    Publishing country United States
    Document type Journal Article
    ZDB-ID 424437-0
    ISSN 1540-8159 ; 0147-8389
    ISSN (online) 1540-8159
    ISSN 0147-8389
    DOI 10.1111/pace.12939
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Screening for Fabry Disease in patients with unexplained left ventricular hypertrophy.

    Chandu Sadasivan / Josie T Y Chow / Bun Sheng / David K H Chan / Yiting Fan / Paul C L Choi / Jeffrey K T Wong / Mabel M B Tong / Tsz-Ngai Chan / Erik Fung / Kevin K H Kam / Joseph Y S Chan / Wai-Kin Chi / D Ian Paterson / Manohara Senaratne / Neil Brass / Gavin Y Oudit / Alex P W Lee

    PLoS ONE, Vol 15, Iss 9, p e

    2020  Volume 0239675

    Abstract: Fabry Disease (FD) is a systemic disorder that can result in cardiovascular, renal, and neurovascular disease leading to reduced life expectancy. FD should be considered in the differential of all patients with unexplained left ventricular hypertrophy ( ... ...

    Abstract Fabry Disease (FD) is a systemic disorder that can result in cardiovascular, renal, and neurovascular disease leading to reduced life expectancy. FD should be considered in the differential of all patients with unexplained left ventricular hypertrophy (LVH). We therefore performed a prospective screening study in Edmonton and Hong Kong using Dried Blood Spot (DBS) testing on patients with undiagnosed LVH. Participants found to have unexplained LVH on echocardiography were invited to participate and subsequently subjected to DBS testing. DBS testing was used to measure α-galactosidase (α-GAL) enzyme activity and for mutation analysis of the α-galactosidase (GLA) gene, both of which are required to make a diagnosis of FD. DBS testing was performed as a screening tool on patients (n = 266) in Edmonton and Hong Kong, allowing for detection of five patients with FD (2% prevalence of FD) and one patient with hydroxychloroquine-induced phenocopy. Left ventricular mass index (LVMI) by GLA genotype showed a higher LVMI in patients with IVS4 + 919G > A mutations compared to those without the mutation. Two patients were initiated on ERT and hydroxychloroquine was discontinued in the patient with a phenocopy of FD. Overall, we detected FD in 2% of our screening cohort using DBS testing as an effective and easy to administer screening tool in patients with unexplained LVH. Utilizing DBS testing to screen for FD in patients with otherwise undiagnosed LVH is clinically important due to the availability of effective therapies and the value of cascade screening in extended families.
    Keywords Medicine ; R ; Science ; Q
    Subject code 610
    Language English
    Publishing date 2020-01-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top